Delivery Order SPE2DB24D2010-SPE2DB24FZYA2
Award Date
9/11/24
Potential Completion Date
9/12/24
Potential Value
$33K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $35,250.60, is a Firm Fixed Price Delivery Order with an ultimate completion date of October 18, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,008.23 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024 with a completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $6,223.32, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 15, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,957.15, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 26, 2024. The contract has a completion date of September 27, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery...
This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the U.S. government. The award was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has a ceiling value of $28,643.95 and is a Firm Fixed Price Delivery Order with a completion date of May 8, 2024. The funding agency is the Defense Logistics Agency (DLA) Troop Support Medical, a component of the...
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,764.91 firm-fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 12, 2024 and was awarded on March 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,020.55 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 3, 2024 with a completion date of June 4, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award, valued at $3,007.71, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 20, 2024. This award is part of a larger Indefinite Delivery...
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET to the Defense Logistics Agency (DLA). The contract, valued at $22,109.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award is a delivery order (SPE2DB22D3401|SPE2DB25FT0RV) valued at $13,346.16 for the supply of RINVOQ ER 30 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...